Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RCCSCAN: DaTSCAN for Clear Cell Renal Cell Carcinoma Diagnosis
NCT03185182Phase 2Terminated
- Sponsor
- Region Skåne
- Start
- Jul 2017
- Primary completion
- Sep 2018
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
A Phase 2 trial of ioflupane I-123 in clear cell renal cell carcinoma (ccRCC), sponsored by Region Skåne. Started Jul 2017; status: terminated.
02
Drugs
ioflupane I-123
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on NCT03185182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03185182.